CTIC STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of CTI BioPharma Corp. Is Fair to Shareholders

Author's Avatar
May 10, 2023

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of CTI BioPharma Corp. (NASDAQ: CTIC) to Swedish Orphan Biovitrum AB for $9.10 per share is fair to CTI BioPharma shareholders.